BACKGROUND: Asthma is the most common chronic disease of childhood and has a strong genetic component. OBJECTIVE: To identify gene expression signatures that reflect asthma-related processes and to determine whether these genes were similar or distinct between stable asthma and acute exacerbations in childhood, we profiled gene expression patterns in nasal respiratory epithelial cells. METHODS: Children who had stable asthma (asthma-S; n = 10) and children experiencing an asthma exacerbation (asthma-E; n = 10) were recruited along with nonatopic children without asthma (n = 10). RNA was prepared from nasal respiratory epithelial cells isolated from each child, initially analyzed as pooled samples from the 3 groups, and further validated by using microarrays and RT-PCR with individual patient samples. RESULTS: Distinct gene clusters were identifiable in individual and pooled asthma-S and asthma-E samples. Asthma-E samples demonstrated the strongest and most reproducible signatures, with 314 genes of 34,886 measured as present on the chip demonstrating induction or repression of greater than 2-fold with P < .05 in each of 4 individual samples. Asthma-S-regulated genes encompassed genes that overlapped with those of asthma-E but were fewer (166) and less consistent with respect to their behavior across the asthma-E patient samples. CONCLUSION: Exacerbated asthma status is readily distinguished based on the occurrence of strong gene expression signatures in nasal epithelial samples. Stable asthma status also exhibits differential signatures. The results suggest that there are independent gene expression signatures reflective of cells and genes poised or committed to activation by an asthma attack.
BACKGROUND: Asthma is the most common chronic disease of childhood and has a strong genetic component. OBJECTIVE: To identify gene expression signatures that reflect asthma-related processes and to determine whether these genes were similar or distinct between stable asthma and acute exacerbations in childhood, we profiled gene expression patterns in nasal respiratory epithelial cells. METHODS:Children who had stable asthma (asthma-S; n = 10) and children experiencing an asthma exacerbation (asthma-E; n = 10) were recruited along with nonatopic children without asthma (n = 10). RNA was prepared from nasal respiratory epithelial cells isolated from each child, initially analyzed as pooled samples from the 3 groups, and further validated by using microarrays and RT-PCR with individual patient samples. RESULTS: Distinct gene clusters were identifiable in individual and pooled asthma-S and asthma-E samples. Asthma-E samples demonstrated the strongest and most reproducible signatures, with 314 genes of 34,886 measured as present on the chip demonstrating induction or repression of greater than 2-fold with P < .05 in each of 4 individual samples. Asthma-S-regulated genes encompassed genes that overlapped with those of asthma-E but were fewer (166) and less consistent with respect to their behavior across the asthma-Epatient samples. CONCLUSION: Exacerbated asthma status is readily distinguished based on the occurrence of strong gene expression signatures in nasal epithelial samples. Stable asthma status also exhibits differential signatures. The results suggest that there are independent gene expression signatures reflective of cells and genes poised or committed to activation by an asthma attack.
Authors: Peggy S Lai; Liming Liang; Edmund S Cibas; Andrew H Liu; Diane R Gold; Andrea Baccarelli; Wanda Phipatanakul Journal: J Allergy Clin Immunol Date: 2015-05-30 Impact factor: 10.793
Authors: Tolly G Epstein; Grace K LeMasters; David I Bernstein; Mark B Ericksen; Lisa J Martin; Patrick H Ryan; Jocelyn M Biagini Myers; Melinda S Butsch Kovacic; Mark A Lindsey; Hua He; Tiina Reponen; Manuel S Villareal; James E Lockey; Cheryl K Bernstein; Gurjit K Khurana Hershey Journal: Ann Allergy Asthma Immunol Date: 2012-03 Impact factor: 6.347
Authors: Damien C Croteau-Chonka; Weiliang Qiu; Fernando D Martinez; Robert C Strunk; Robert F Lemanske; Andrew H Liu; Frank D Gilliland; Joshua Millstein; W James Gauderman; Carole Ober; Jerry A Krishnan; Steven R White; Edward T Naureckas; Dan L Nicolae; Kathleen C Barnes; Stephanie J London; Albino Barraza-Villarreal; Vincent J Carey; Scott T Weiss; Benjamin A Raby Journal: Am J Respir Crit Care Med Date: 2017-01-15 Impact factor: 21.405
Authors: Sara L Hall; Theresa Baker; Stephane Lajoie; Phoebe K Richgels; Yanfen Yang; Jaclyn W McAlees; Adelaide van Lier; Marsha Wills-Karp; Umasundari Sivaprasad; Thomas H Acciani; Timothy D LeCras; Jocelyn Biagini Myers; Melinda Butsch Kovacic; Ian P Lewkowich Journal: J Allergy Clin Immunol Date: 2016-06-11 Impact factor: 10.793
Authors: Kathy T Schroer; Aaron M Gibson; Umasundari Sivaprasad; Stacey A Bass; Mark B Ericksen; Marsha Wills-Karp; Tim Lecras; Anne M Fitzpatrick; Lou Ann S Brown; Keith F Stringer; Gurjit K Khurana Hershey Journal: J Allergy Clin Immunol Date: 2011-05-13 Impact factor: 10.793
Authors: Pamela L Zeitlin; Marie Diener-West; Karen A Callahan; Seakwoo Lee; C Conover Talbot; Bette Pollard; Michael P Boyle; Noah Lechtzin Journal: Ann Am Thorac Soc Date: 2017-02
Authors: Umasundari Sivaprasad; David J Askew; Mark B Ericksen; Aaron M Gibson; Matthew T Stier; Eric B Brandt; Stacey A Bass; Michael O Daines; Jamila Chakir; Keith F Stringer; Susan E Wert; Jeffrey A Whitsett; Timothy D Le Cras; Marsha Wills-Karp; Gary A Silverman; Gurjit K Khurana Hershey Journal: J Allergy Clin Immunol Date: 2010-12-03 Impact factor: 10.793
Authors: Premkumar Vummidi Giridhar; Sheila M Bell; Anusha Sridharan; Priya Rajavelu; Joseph A Kitzmiller; Cheng-Lun Na; Matthew Kofron; Eric B Brandt; Mark Ericksen; Anjaparavanda P Naren; Changsuk Moon; Gurjit K Khurana Hershey; Jeffrey A Whitsett Journal: J Immunol Date: 2016-10-28 Impact factor: 5.422
Authors: Chang Xiao; Jocelyn M Biagini Myers; Hong Ji; Kelly Metz; Lisa J Martin; Mark Lindsey; Hua He; Racheal Powers; Ashley Ulm; Brandy Ruff; Mark B Ericksen; Hari K Somineni; Jeffrey Simmons; Richard T Strait; Carolyn M Kercsmar; Gurjit K Khurana Hershey Journal: J Allergy Clin Immunol Date: 2015-04-21 Impact factor: 10.793